The Company will highlight integrated clinical and genomic insights generated through its Oncology Data Solutions platform
A Look Back at Testing & Diagnostics Services Stocks’ Q4 Earnings: NeoGenomics (NASDAQ:NEO) Vs The Rest Of The Pack
3 Cash-Burning Stocks We Think Twice About
NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that it will report its first quarter 2026 financial results...
3 of Wall Street’s Favorite Stocks We Think Twice About
2 High-Flying Stocks to Consider Right Now and 1 That Underwhelm
3 Russell 2000 Stocks We Approach with Caution
NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know
NeoGenomics, Inc. (NASDAQ: NEO) , a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the PanTracer™ LBx test has received coverage from the Centers...
3 Reasons to Avoid NEO and 1 Stock to Buy Instead